DK96986A - Kemiske forbindelser - Google Patents

Kemiske forbindelser Download PDF

Info

Publication number
DK96986A
DK96986A DK96986A DK96986A DK96986A DK 96986 A DK96986 A DK 96986A DK 96986 A DK96986 A DK 96986A DK 96986 A DK96986 A DK 96986A DK 96986 A DK96986 A DK 96986A
Authority
DK
Denmark
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
DK96986A
Other languages
English (en)
Other versions
DK96986D0 (da
DK166582B1 (da
Inventor
Ole Bent Tvaermose Nielsen
Ian Ahnfelt-Roenne
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506094A external-priority patent/GB8506094D0/en
Priority claimed from GB858525153A external-priority patent/GB8525153D0/en
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of DK96986D0 publication Critical patent/DK96986D0/da
Publication of DK96986A publication Critical patent/DK96986A/da
Application granted granted Critical
Publication of DK166582B1 publication Critical patent/DK166582B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • C07D213/34Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK096986A 1985-03-08 1986-03-04 Pyridylmethoxyderivater og farmaceutisk acceptable salte og lethydrolyserbare estre deraf, deres fremstilling og farmaceutisk praeparat indeholdende samme DK166582B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8506094 1985-03-08
GB858506094A GB8506094D0 (en) 1985-03-08 1985-03-08 Chemical products
GB8525153 1985-10-11
GB858525153A GB8525153D0 (en) 1985-10-11 1985-10-11 Chemical compounds

Publications (3)

Publication Number Publication Date
DK96986D0 DK96986D0 (da) 1986-03-04
DK96986A true DK96986A (da) 1986-09-09
DK166582B1 DK166582B1 (da) 1993-06-14

Family

ID=26288945

Family Applications (1)

Application Number Title Priority Date Filing Date
DK096986A DK166582B1 (da) 1985-03-08 1986-03-04 Pyridylmethoxyderivater og farmaceutisk acceptable salte og lethydrolyserbare estre deraf, deres fremstilling og farmaceutisk praeparat indeholdende samme

Country Status (18)

Country Link
US (2) US4826987A (da)
JP (1) JPH0764813B2 (da)
AU (1) AU585586B2 (da)
BE (1) BE904368A (da)
CA (1) CA1276640C (da)
DE (1) DE3607382A1 (da)
DK (1) DK166582B1 (da)
ES (1) ES8802610A1 (da)
FR (1) FR2578540B1 (da)
GB (1) GB2173788B (da)
GR (1) GR860628B (da)
IE (1) IE58870B1 (da)
IT (1) IT1221079B (da)
LU (1) LU86349A1 (da)
NL (1) NL8600596A (da)
NZ (1) NZ215347A (da)
PT (1) PT82147B (da)
SE (1) SE463819B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
DK196688A (da) * 1987-04-28 1988-10-29 Fujisawa Pharmaceutical Co Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
US4889935A (en) * 1987-12-18 1989-12-26 American Home Products Corporation Aminoguanidine derivatives
US5248685A (en) * 1989-04-07 1993-09-28 Pfizer Inc. Substituted 1-[3-(heteroarylmethoxy)phenyl]alkanols and related compounds in the treatment of asthma
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3935139A1 (de) * 1989-10-21 1991-04-25 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-thioharnstoffe
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
US5324747A (en) * 1992-07-15 1994-06-28 Hoffmann-La Roche Inc. N-substituted anilines, inhibitors of phospholipases A2
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US5508408A (en) * 1993-09-10 1996-04-16 Ciba-Geigy Corporation Quinoline compound
US5795900A (en) * 1995-10-03 1998-08-18 Abbott Laboratories Symmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
US5668150A (en) * 1996-07-26 1997-09-16 Abbott Laboratories Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
DE69822514T2 (de) * 1997-12-31 2005-03-24 The University Of Kansas, Lawrence Wasserlösliche pro-pharmaka von arzneistoffen, die ein tertiäres amin enthalten, und verfahren zu ihrer herstellung
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) * 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
TW200920369A (en) * 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
US20110160249A1 (en) * 2008-05-23 2011-06-30 Schaab Kevin Murray 5-lipoxygenase-activating protein inhibitor
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
TW201215607A (en) 2010-07-02 2012-04-16 Lundbeck & Co As H Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31624A (en) * 1861-03-05 Tatting-frame
US2761865A (en) * 1954-07-07 1956-09-04 Hoffmann La Roche Pyridylalkyl sulfones
US4003906A (en) * 1974-01-22 1977-01-18 The Dow Chemical Company Substituted pyridinyl methylthio or (methylsulfonyl)benzeneamines
GB2069493B (en) * 1980-02-20 1984-02-29 Wyeth John & Brother Ltd Pyridine derivatives
GB2069492B (en) * 1980-02-20 1984-02-29 Wyeth John & Brother Ltd Sulphur compounds
US4567184A (en) * 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
JPS5988835U (ja) * 1982-12-06 1984-06-15 ホシデン株式会社 スイツチ
US4486593A (en) * 1983-01-19 1984-12-04 The Upjohn Company 2-,3-, or 4-Pyridinylmethylamino arylic acids as thromboxane A2 synthetase and 5-lipoxygenase inhibitors
US4563463A (en) * 1983-03-18 1986-01-07 Usv Pharmaceutical Corp. 2-Oxo-1,3-oxazolo[4,5-h] quinolines useful as anti-allergy agents
US4554355A (en) * 1984-07-19 1985-11-19 American Home Products Corporation Heterocyclic compounds as antiallergic agents
US5109009A (en) * 1985-03-08 1992-04-28 Leo Pharmaceutical Products Ltd. Quinoline and pyridine compounds and inhibition of 5-lipoxygenases therewith

Also Published As

Publication number Publication date
NL8600596A (nl) 1986-10-01
PT82147A (en) 1986-04-01
SE8600913L (sv) 1986-09-09
IE860370L (en) 1986-09-08
PT82147B (pt) 1988-07-29
DK96986D0 (da) 1986-03-04
AU5444486A (en) 1986-09-18
IT1221079B (it) 1990-06-21
SE463819B (sv) 1991-01-28
GB2173788B (en) 1988-08-10
GR860628B (en) 1986-06-26
DK166582B1 (da) 1993-06-14
BE904368A (fr) 1986-09-08
US5157039A (en) 1992-10-20
CA1276640C (en) 1990-11-20
ES8802610A1 (es) 1988-09-16
JPH0764813B2 (ja) 1995-07-12
US4826987A (en) 1989-05-02
GB8604183D0 (en) 1986-03-26
LU86349A1 (fr) 1987-04-02
FR2578540A1 (fr) 1986-09-12
FR2578540B1 (fr) 1990-11-16
ES552805A0 (es) 1988-09-16
JPS61207374A (ja) 1986-09-13
AU585586B2 (en) 1989-06-22
GB2173788A (en) 1986-10-22
DE3607382A1 (de) 1986-09-11
IE58870B1 (en) 1993-11-17
IT8667183A0 (it) 1986-03-06
SE8600913D0 (sv) 1986-02-28
NZ215347A (en) 1990-02-26

Similar Documents

Publication Publication Date Title
DK406586D0 (da) Kemiske forbindelser
DK380986D0 (da) Kemisk fremgangsmaade
DE3650706D1 (de) Substituierte Dicarboxypyridin-Verbindungen
DK40788D0 (da) Kemiske forbindelser
DK356686D0 (da) Kemiske forbindelser
DK96986D0 (da) Kemiske forbindelser
DK90788D0 (da) Kemiske forbindelser
ATE57380T1 (de) Pyridinylimidazolidinon-verbindungen.
DK477186A (da) Indolobenzodiazepinforbindelser
DK301885D0 (da) Kemiske forbindelser
DK109886D0 (da) Kemiske forbindelser
DK483689D0 (da) Kemiske forbindelser
DK360486A (da) Pesticide forbindelser
DE3677925D1 (de) Isochinolin-verbindungen.
DK429986A (da) 2-oxa-isocephemforbindelser
DK346186D0 (da) Kemiske forbindelser
DE3666434D1 (de) Oxodiazine compounds
DK135886D0 (da) Cyanoalkanimidamidoforbindelser
DK187686D0 (da) Benzisothiazol-s-oxidforbindelse
DK514785D0 (da) Kemisk fremgangsmaade
IT8647773A0 (it) Perfezionamenti riguardanti composti organici
DK148986D0 (da) Biocide tributhyltinforbindelser
BR8605955A (pt) Compostos de pirazolina
DK65786D0 (da) Kemiske forbindelser
IT8647794A0 (it) Perfezionamenti riguardanti composti organici

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed